帕金森病中Covid-19的患病率和结局：急性环境和医院

3区医学 Q2 Medicine

International review of neurobiology Pub Date : 2022-01-01 Epub Date: 2022-04-20 DOI:10.1016/bs.irn.2022.03.001

Conor Fearon, Alfonso Fasano

{"title":"帕金森病中Covid-19的患病率和结局：急性环境和医院","authors":"Conor Fearon, Alfonso Fasano","doi":"10.1016/bs.irn.2022.03.001","DOIUrl":null,"url":null,"abstract":"The global explosion of COVID-19 necessitated the rapid dissemination of information regarding SARS-CoV-2. Hence, COVID-19 prevalence and outcome data in Parkinson's disease patients were disseminated at a time when we only had part of the picture. In this chapter we firstly discuss the current literature on the prevalence of COVID-19 in people with PD. We then discuss outcomes from COVID-19 in people with PD, specifically risk of hospitalization and mortality. Finally, we discuss specific contributing and confounding factors which may put PD patients at higher or lower risk from COVID-19.","PeriodicalId":14468,"journal":{"name":"International review of neurobiology","volume":"165 ","pages":"35-62"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020798/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital.\",\"authors\":\"Conor Fearon, Alfonso Fasano\",\"doi\":\"10.1016/bs.irn.2022.03.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The global explosion of COVID-19 necessitated the rapid dissemination of information regarding SARS-CoV-2. Hence, COVID-19 prevalence and outcome data in Parkinson's disease patients were disseminated at a time when we only had part of the picture. In this chapter we firstly discuss the current literature on the prevalence of COVID-19 in people with PD. We then discuss outcomes from COVID-19 in people with PD, specifically risk of hospitalization and mortality. Finally, we discuss specific contributing and confounding factors which may put PD patients at higher or lower risk from COVID-19.\",\"PeriodicalId\":14468,\"journal\":{\"name\":\"International review of neurobiology\",\"volume\":\"165 \",\"pages\":\"35-62\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020798/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International review of neurobiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/bs.irn.2022.03.001\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/4/20 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International review of neurobiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/bs.irn.2022.03.001","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/4/20 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

COVID-19在全球爆发，需要迅速传播有关SARS-CoV-2的信息。因此，在我们只掌握部分情况的时候，帕金森病患者的COVID-19患病率和结果数据就被传播了。在本章中，我们首先讨论了目前关于PD患者中COVID-19患病率的文献。然后讨论COVID-19对PD患者的影响，特别是住院和死亡风险。最后，我们讨论了可能使PD患者患COVID-19风险更高或更低的具体促成因素和混杂因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital.

The global explosion of COVID-19 necessitated the rapid dissemination of information regarding SARS-CoV-2. Hence, COVID-19 prevalence and outcome data in Parkinson's disease patients were disseminated at a time when we only had part of the picture. In this chapter we firstly discuss the current literature on the prevalence of COVID-19 in people with PD. We then discuss outcomes from COVID-19 in people with PD, specifically risk of hospitalization and mortality. Finally, we discuss specific contributing and confounding factors which may put PD patients at higher or lower risk from COVID-19.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

International review of neurobiology NEUROSCIENCES-

CiteScore

5.90

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Published since 1959, International Review of Neurobiology is a well-established series appealing to neuroscientists, clinicians, psychologists, physiologists and pharmacologists. Led by an internationally renowned editorial board, this important serial publishes both eclectic volumes made up of timely reviews and thematic volumes that focus on recent progress in a specific area of neurobiology research.